Circulating levels of soluble α-klotho and fgf23 in childhood cancer survivors: lack of association with nephro- and cardiotoxicity—a preliminary study

HIGHLIGHTS

• What: The aims of this study were to assess the serum α-Klotho and FGF23 levels in CCSs and to determine their association with nephro- and Methods: This study evaluated cohort of 66 CCSs who remained in continuous remission with mean follow-up of 8.41 ± 3.76 years. The aim of this study was to investigate whether childhood cancer treatment affects the levels of soluble α-Klotho and fibroblast growth factor-23 in survivors of childhood cancer several years after treatment, as well as their relationship to kidney damage and cardiovascular disease. In the present study, a significant . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.